Biotechnology Fund Class Fund Buy Hold or Sell Recommendation
| RYBOX Fund | USD 67.96 1.02 1.52% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Biotechnology Fund Class is 'Strong Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Biotechnology Fund Class given historical horizon and risk tolerance towards Biotechnology Fund. When Macroaxis issues a 'buy' or 'sell' recommendation for Biotechnology Fund Class, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Biotechnology Fund Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual funds such as Biotechnology and provide practical buy, sell, or hold recommendation based on investors' investing horizon and their risk tolerance towards Biotechnology Fund Class. Also, note that the market value of any mutual fund could be closely tied with the direction of predictive economic indicators such as signals in persons.
Biotechnology |
Execute Biotechnology Fund Buy or Sell Advice
The Biotechnology recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Biotechnology Fund Class. Macroaxis does not own or have any residual interests in Biotechnology Fund Class or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Biotechnology Fund's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details |
Biotechnology Fund Trading Alerts and Improvement Suggestions
| Biotechnology Fund generated a negative expected return over the last 90 days | |
| The fund generated three year return of -2.0% | |
| Biotechnology Fund Class maintains 98.56% of its assets in stocks |
Biotechnology Fund Returns Distribution Density
The distribution of Biotechnology Fund's historical returns is an attempt to chart the uncertainty of Biotechnology Fund's future price movements. The chart of the probability distribution of Biotechnology Fund daily returns describes the distribution of returns around its average expected value. We use Biotechnology Fund Class price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Biotechnology Fund returns is essential to provide solid investment advice for Biotechnology Fund.
| Mean Return | -0.08 | Value At Risk | -1.75 | Potential Upside | 1.41 | Standard Deviation | 1.08 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Biotechnology Fund historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Biotechnology Fund Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Biotechnology Fund or Rydex Funds sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Biotechnology Fund's price will be affected by overall mutual fund market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Biotechnology fund's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.19 | |
β | Beta against Dow Jones | 0.87 | |
σ | Overall volatility | 1.10 | |
Ir | Information ratio | -0.19 |
Biotechnology Fund Volatility Alert
Biotechnology Fund Class exhibits very low volatility with skewness of -1.24 and kurtosis of 3.05. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Biotechnology Fund's mutual fund risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Biotechnology Fund's mutual fund price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Biotechnology Fund Fundamentals Vs Peers
Comparing Biotechnology Fund's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Biotechnology Fund's direct or indirect competition across all of the common fundamentals between Biotechnology Fund and the related equities. This way, we can detect undervalued stocks with similar characteristics as Biotechnology Fund or determine the mutual funds which would be an excellent addition to an existing portfolio. Peer analysis of Biotechnology Fund's fundamental indicators could also be used in its relative valuation, which is a method of valuing Biotechnology Fund by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Biotechnology Fund to competition |
| Fundamentals | Biotechnology Fund | Peer Average |
| Price To Earning | 18.21 X | 6.53 X |
| Price To Book | 3.49 X | 0.74 X |
| Price To Sales | 4.68 X | 0.61 X |
| Year To Date Return | 4.20 % | 0.39 % |
| One Year Return | 19.99 % | 4.15 % |
| Three Year Return | (1.54) % | 3.60 % |
| Five Year Return | 4.16 % | 3.24 % |
| Ten Year Return | 17.31 % | 1.79 % |
| Net Asset | 117.21 M | 4.11 B |
| Minimum Initial Investment | 2.5 K | 976.16 K |
| Cash Position Weight | 1.44 % | 10.61 % |
| Equity Positions Weight | 98.56 % | 63.90 % |
Biotechnology Fund Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Biotechnology . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 67.96 | |||
| Day Typical Price | 67.96 | |||
| Price Action Indicator | 0.51 | |||
| Period Momentum Indicator | 1.02 | |||
| Relative Strength Index | 64.6 |
About Biotechnology Fund Buy or Sell Advice
When is the right time to buy or sell Biotechnology Fund Class? Buying financial instruments such as Biotechnology Mutual Fund isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Biotechnology Fund in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sector ETFs Thematic Idea Now
Sector ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sector ETFs theme has 440 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sector ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |